Asia Pacific Peptide Drug Conjugates Market Size & Outlook
Asia Pacific peptide drug conjugates market, 2018-2030 (US$M)
Related Markets
Asia Pacific peptide drug conjugates market highlights
- The Asia Pacific peptide drug conjugates market generated a revenue of USD 140.4 million in 2023.
- The market is expected to grow at a CAGR of 31.3% from 2024 to 2030.
- In terms of segment, therapeutics was the largest revenue generating type in 2023.
- Therapeutics is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 140.4 million |
| Market revenue in 2030 | USD 943.7 million |
| Growth rate | 31.3% (CAGR from 2023 to 2030) |
| Largest segment | Therapeutics |
| Fastest growing segment | Therapeutics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Therapeutics, Diagnostics |
| Key market players worldwide | Novartis AG ADR, Oncopeptides AB, Bicycle Therapeutics PLC ADR, AstraZeneca PLC, Theratechnologies Inc, Cybrexa Therapeutics, AngioChem, Soricimed |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.4% of the global peptide drug conjugates market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 943.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peptide Drug Conjugates Market Scope
Peptide Drug Conjugates Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific peptide drug conjugates market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peptide drug conjugates market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 81.48% in 2023. Horizon Databook has segmented the Asia Pacific peptide drug conjugates market based on therapeutics, diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
The peptide drug conjugates market in the Asia Pacific is expected to grow at the fastest rate over the forecast period owing to improving healthcare reforms in the region. Other factors contributing to the market growth are the increasing geriatric population, improving healthcare infrastructure, and entry of new players.
Some of the major players operating in the Asia Pacific market are Novartis AG, Thera technologies Inc., and On copeptides AB. Increasing initiatives for scientific research & positive economic growth coupled with high unmet needs are among the drivers of this market.
Moreover, improving healthcare regulatory scenario in high-growth countries is expected to attract international players to invest and capitalize on the available opportunities. Positive changes, such as healthcare benefits by the government, increased awareness amongst the population, and an urge to avail high-end medical treatment, are also expected to drive regional market growth.
Reasons to subscribe to Asia Pacific peptide drug conjugates market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific peptide drug conjugates market databook
-
Our clientele includes a mix of peptide drug conjugates market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific peptide drug conjugates market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific peptide drug conjugates market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific peptide drug conjugates market size, by country, 2018-2030 (US$M)
Asia Pacific Peptide Drug Conjugates Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
